Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy

Molecular Diagnosis & Therapy
Patricia LlovetEduardo Díaz-Rubio

Abstract

Mutational analysis of RAS is required for anti-epidermal growth factor receptor (EGFR) treatment for patients with metastatic colorectal cancer (mCRC). However, most patients with KRAS wild-type tumors still do not respond. Other molecules downstream of the EGFR may also play a role in resistance to EGFR therapies. Our objective was to investigate the clinical importance of biomarkers in relation to response, progression-free survival, and overall survival in patients with mCRC receiving first-line treatment with anti-EGFR therapy plus chemotherapy. We studied the EGFR pathway [EGFR, NRAS, BRAF, PIK3CA, phosphatase and tensin homolog (PTEN), amphiregulin (AREG), and epiregulin (EREG)] in 105 patients with mCRC KRAS codon 12 wild type. We analysed objective response, progression-free survival, and overall survival in molecularly defined subgroups of the patients receiving anti-EGFR therapy plus chemotherapy as first-line treatment. We found a significant association between RAS wild-type, BRAF wild-type, EREG, and AREG overexpression and response to anti-EGFR therapy (p = 0.003, p = 0.015, p = 0.05, and p = 0.009, respectively). Progression-free survival and overall survival were lower in patients with RAS (p = 0.36 and p ≤ 0.0...Continue Reading

References

Apr 19, 2006·Cancer Research·Astrid LièvrePierre Laurent-Puig
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shirin Khambata-FordDavid J Mauro
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea Sartore-BianchiSalvatore Siena
Oct 18, 2007·British Journal of Cancer·M FrattiniL Mazzucchelli
Nov 3, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F CappuzzoM Varella-Garcia
Jan 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Astrid LièvrePierre Laurent-Puig
Aug 2, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F PerroneS Pilotti
Sep 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nicola PersoneniSabine Tejpar
Nov 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federica Di NicolantonioAlberto Bardelli
Apr 3, 2009·The New England Journal of Medicine·Eric Van CutsemPhilippe Rougier
Apr 16, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hans PrenenSabine Tejpar
Apr 29, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fotios LoupakisAlfredo Falcone
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bart JacobsSabine Tejpar
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan D RichmanPhilip Quirke
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pierre Laurent-PuigFrédérique Penault-Llorca
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alberto Bardelli, Salvatore Siena
Jan 14, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C BokemeyerP Koralewski
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemFortunato Ciardiello
Nov 3, 2011·Anti-cancer Agents in Medicinal Chemistry·Tomoya Yokota
Mar 27, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Carsten BokemeyerClaus-Henning Köhne
Aug 18, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Amanda I PhippsPolly A Newcomb
Sep 3, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Deniz TuralSüheyla Serdengeçti
Sep 13, 2013·The New England Journal of Medicine·Jean-Yves DouillardScott D Patterson
Nov 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Oriana YuLaurent Azoulay
Nov 13, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christos S KarapetisUNKNOWN NCIC Clinical Trials Group and the Australasian Gastro-Intestinal Trials Group

❮ Previous
Next ❯

Citations

Oct 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jiao YangJin Yang
Nov 24, 2016·International Journal of Cancer. Journal International Du Cancer·Annika ÅlgarsRaija Ristamäki
Jan 2, 2019·Gastroenterology Research and Practice·Catherine E Bond, Vicki L J Whitehall
Jun 11, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P García-AlfonsoM Martin
Aug 30, 2016·World Journal of Gastroenterology : WJG·Cristiana Lo NigroMarco C Merlano
Sep 19, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Arndt StahlerVolker Heinemann

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.